Evidence brief · Supplement

Fisetin for Senolytic / healthspan (humans)

Evidence grade D — No completed human outcomes

Overall grade
Grade D
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade D — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Senolytic / healthspan (humans)Evidence grade D

    No completed human outcomes

    Unclearlow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Senolytic / healthspan (humans) (grade D).

The evidence in words

The verdict

For senolytic / healthspan (humans), Fisetin earns evidence grade D (unclear effect, low consistency) — the evidence does not support the claim. No completed human outcomes

How it might work

It appears to clear senescent 'zombie' cells that accumulate with age and drive inflammation.

How to use it

Experimental; some protocols use intermittent high doses — not established.

Safety & cautions

Food flavonoid, appears safe; human dosing unestablished.

Bottom line

Exciting in mice, unproven in humans. Wait for the trials before betting on it.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Experimental
Not established.

Goes with

  • FisetinRead the full Fisetin monographEvidence grade D

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.